Status:

COMPLETED

Blood Glucose Self Monitoring and HbA1c Effects on Glucose Control

Lead Sponsor:

Deutsche Diabetes Gesellschaft

Collaborating Sponsors:

Bayer

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

40-80 years

Phase:

PHASE4

Brief Summary

The purpose of this randomized, prospective trial is to determine wether (a) a once weekly glucose profile (self monitoring) or (b) a three-monthly report of the actual glycated haemoglobin are effect...

Detailed Description

The design is an open, prospective, randomised, multicentre parallel group study. The total duration will be 5 years with patient recruitment over 4 years and an individual observation period of 1 yea...

Eligibility Criteria

Inclusion

  • Type 2-diabetes (ADA/WHO-Criteria)
  • Conventional insulin therapy ( 1-3 daily injections of basal- and/or mixed insulin also in combination with oral agents.)
  • Age:\> 40 years
  • BMI:\> 20 kg/m²

Exclusion

  • Impaired liver function, defined as \> 2 times upper limit of normal
  • Impaired renal function defined liver enzymes as serum-creatinine \> 1.3 mg/dl
  • Gastro-intestinal diseases (disturbances, diagnoses)
  • Inability to perform study-related activities according to the present protocol
  • Pregnancy not certainly excluded
  • Abuse of alcohol and/or other drugs
  • Participation in other clinical trials during the past 3 month
  • Threat to general state of health
  • Intensified insulin therapy (at least 3 times rapid-acting insulin)
  • Frequent blood glucose self monitoring during the past 3 months (more than one 4-point glucose profile per week or more than one blood glucose/ urinary glucose test per day )

Key Trial Info

Start Date :

February 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT00688363

Start Date

February 1 2003

End Date

December 1 2008

Last Update

August 1 2011

Active Locations (41)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 11 (41 locations)

1

Diabeteszentrum Bad Lauterberg

Bad Lauterberg im Harz, Lower Saxony, Germany, D-37431

2

Koch, Peter

Bad Harzburg, Germany, 38667

3

Maxeiner, Stefan

Bad Kreuznach, Germany, 55545

4

Friedrichs, Michael

Bad Lauterberg im Harz, Germany, 37431